Intern Med J. 2021 Feb;51(2):284-287. doi: 10.1111/imj.15190.

Ralley E Prentice ¹, Aysha Al-Ani ¹, Britt Christensen ¹

Author information

• ¹Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Abstract

The COVID-19 pandemic has demanded a rapid adaptation in healthcare provision, including patients with inflammatory bowel disease (IBD). This viewpoint discusses some of the unique challenges in managing comorbid IBD and COVID-10 experienced by our team at The Royal Melbourne Hospital, which was at the epicentre of the COVID-19 'second-wave' surge in Melbourne.